Literature DB >> 2157444

Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils.

W H Betts1, N P Hurst, G A Murphy, L G Cleland.   

Abstract

The effect of auranofin on the 5-lipoxygenase pathway was studied in human neutrophils stimulated with either fMLP or A23187 (with or without arachidonic acid). The synthesis of leukotriene B4 (LTB4), 5-HETE and the all-trans isomers of LTB4 was measured by HPLC. At low concentrations (0.5-2.0 microM), auranofin stimulated LTB4 synthesis, but inhibited it at higher concentrations (100% inhibition at less than 10 microM). In contrast auranofin caused dose-dependent inhibition of the synthesis of 5-HETE and the all-trans isomers of LTB4. Similar observations were made with each agonist. The stimulation of LTB4 synthesis and inhibition of the trans isomer production suggests that auranofin at low concentrations stimulates LTA hydrolase--the enzyme that converts LTA4 to LTB4, whereas the inhibition of synthesis of all lipoxygenase products at higher auranofin concentrations, suggests inhibition of 5-lipoxygenase/LTA synthase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157444     DOI: 10.1016/0006-2952(90)90268-p

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Auranofin and its combination with LTB4 influences ATP level and migration of human polymorphonuclear cells in vitro.

Authors:  G Partsch; M Matucci-Cerinic
Journal:  Inflammation       Date:  1995-06       Impact factor: 4.092

2.  Potentiation and inhibition of migration of human neutrophils by auranofin.

Authors:  J G Elferink; B M de Koster
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

3.  Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis.

Authors:  George B Lenon; Charlie C L Xue; David F Story; Frank C K Thien; Sarah McPhee; Chun G Li
Journal:  Chin Med       Date:  2007-02-15       Impact factor: 5.455

4.  Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel.

Authors:  M W Whitehouse; T A Macrides; N Kalafatis; W H Betts; D R Haynes; J Broadbent
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 5.093

5.  Inhibition of release of vasoactive and inflammatory mediators in airway and vascular tissues and macrophages by a chinese herbal medicine formula for allergic rhinitis.

Authors:  George Binh Lenon; Chun Guang Li; Charlie Changli Xue; Francis Chung Kong Thien; David Frederick Story
Journal:  Evid Based Complement Alternat Med       Date:  2006-11-27       Impact factor: 2.629

6.  CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.

Authors:  Richard E Kast; Georg Karpel-Massler; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2014-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.